Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $2.6 million.

  • Aspen Aerogels' Share-based Compensation rose 45.63% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.5 million, marking a year-over-year decrease of 2238.61%. This contributed to the annual value of $12.9 million for FY2024, which is 1735.44% up from last year.
  • Aspen Aerogels' Share-based Compensation amounted to $2.6 million in Q3 2025, which was up 45.63% from $3.2 million recorded in Q2 2025.
  • Aspen Aerogels' Share-based Compensation's 5-year high stood at $4.7 million during Q1 2024, with a 5-year trough of $976000.0 in Q1 2021.
  • Its 5-year average for Share-based Compensation is $2.4 million, with a median of $2.6 million in 2022.
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 11448.6% in 2022, then crashed by 5594.99% in 2025.
  • Over the past 5 years, Aspen Aerogels' Share-based Compensation (Quarter) stood at $1.6 million in 2021, then soared by 69.54% to $2.7 million in 2022, then grew by 19.31% to $3.2 million in 2023, then fell by 20.08% to $2.5 million in 2024, then grew by 3.69% to $2.6 million in 2025.
  • Its Share-based Compensation stands at $2.6 million for Q3 2025, versus $3.2 million for Q2 2025 and $2.1 million for Q1 2025.